Cogentix Medical (Cogentix Medical) 6-1 Month Momentum % : N/A% (As of Apr. 30, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-30), Cogentix Medical's 6-1 Month Momentum % is N/A%.

The industry rank for Cogentix Medical's 6-1 Month Momentum % or its related term are showing as below:

CGNT's 6-1 Month Momentum % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.7
* Ranked among companies with meaningful 6-1 Month Momentum % only.

Competitive Comparison of Cogentix Medical's 6-1 Month Momentum %

For the Medical Devices subindustry, Cogentix Medical's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogentix Medical's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's 6-1 Month Momentum % falls into.

Cogentix Medical (NAS:CGNT) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %

( Price 1-month ago

Price 6-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogentix Medical (NAS:CGNT) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Cogentix Medical 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cogentix Medical (Cogentix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » 6-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5420 Feltl Road, Minnetonka, MN, USA, 55343

Website

http://www.cogentixmedical.com

Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.

Executives

Nachum Shamir	director	12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds	officer: SVP, CFO, Treasurer	5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet	director	800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger	director	221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p.	10 percent owner	6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus	director	40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus	director	5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein	director
Kevin H Roche	director
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010